Fig. 3From: Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndromeSeverity of liver injury assessed by DeLeve score in each group. Group A: control group; Group B: HSOS model group; Group C: low dose LMWH group; Group D: high dose LMWH group; Group E: defibrotide group.Back to article page